Decision Diagnostics Stock Probability of Future Stock Price Finishing Over 8.4E-5

DECN Stock  USD 0.0001  0.00  0.00%   
Decision Diagnostics' future price is the expected price of Decision Diagnostics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Decision Diagnostics performance during a given time horizon utilizing its historical volatility. Check out Decision Diagnostics Backtesting, Decision Diagnostics Valuation, Decision Diagnostics Correlation, Decision Diagnostics Hype Analysis, Decision Diagnostics Volatility, Decision Diagnostics History as well as Decision Diagnostics Performance.
To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.
  
At this time, Decision Diagnostics' Price Book Value Ratio is very stable compared to the past year. As of the 2nd of December 2024, Price To Book Ratio is likely to grow to 9.38, while Price To Sales Ratio is likely to drop 2.65. Please specify Decision Diagnostics' target price for which you would like Decision Diagnostics odds to be computed.

Decision Diagnostics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Decision Diagnostics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Decision Diagnostics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Decision Diagnostics generated a negative expected return over the last 90 days
Decision Diagnostics has some characteristics of a very speculative penny stock
Decision Diagnostics has a very high chance of going through financial distress in the upcoming years
Decision Diagnostics currently holds 2.93 M in liabilities with Debt to Equity (D/E) ratio of 9.05, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Decision Diagnostics has a current ratio of 0.25, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Decision Diagnostics' use of debt, we should always consider it together with its cash and equity.
The entity reported the previous year's revenue of 1.98 M. Net Loss for the year was (29.67 M) with profit before overhead, payroll, taxes, and interest of 194.17 K.
Decision Diagnostics currently holds about 210.85 K in cash with (1.4 M) of positive cash flow from operations.
Decision Diagnostics has a frail financial position based on the latest SEC disclosures
Latest headline from news.google.com: Plus Therapeutics CNSide Trial Shows 90 percent Success in Cancer Treatment Decisions PSTV Stock News - StockTitan

Decision Diagnostics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Decision Stock often depends not only on the future outlook of the current and potential Decision Diagnostics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Decision Diagnostics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding356.4 M

Decision Diagnostics Technical Analysis

Decision Diagnostics' future price can be derived by breaking down and analyzing its technical indicators over time. Decision Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Decision Diagnostics. In general, you should focus on analyzing Decision Stock price patterns and their correlations with different microeconomic environments and drivers.

Decision Diagnostics Predictive Forecast Models

Decision Diagnostics' time-series forecasting models is one of many Decision Diagnostics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Decision Diagnostics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Decision Diagnostics

Checking the ongoing alerts about Decision Diagnostics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Decision Diagnostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Decision Diagnostics generated a negative expected return over the last 90 days
Decision Diagnostics has some characteristics of a very speculative penny stock
Decision Diagnostics has a very high chance of going through financial distress in the upcoming years
Decision Diagnostics currently holds 2.93 M in liabilities with Debt to Equity (D/E) ratio of 9.05, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Decision Diagnostics has a current ratio of 0.25, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Decision Diagnostics' use of debt, we should always consider it together with its cash and equity.
The entity reported the previous year's revenue of 1.98 M. Net Loss for the year was (29.67 M) with profit before overhead, payroll, taxes, and interest of 194.17 K.
Decision Diagnostics currently holds about 210.85 K in cash with (1.4 M) of positive cash flow from operations.
Decision Diagnostics has a frail financial position based on the latest SEC disclosures
Latest headline from news.google.com: Plus Therapeutics CNSide Trial Shows 90 percent Success in Cancer Treatment Decisions PSTV Stock News - StockTitan
When determining whether Decision Diagnostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Decision Diagnostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Decision Diagnostics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Decision Diagnostics Stock:
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Decision Diagnostics. If investors know Decision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Decision Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.02)
Revenue Per Share
0.006
Quarterly Revenue Growth
(0)
Return On Assets
(0.21)
Return On Equity
(81.61)
The market value of Decision Diagnostics is measured differently than its book value, which is the value of Decision that is recorded on the company's balance sheet. Investors also form their own opinion of Decision Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Decision Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Decision Diagnostics' market value can be influenced by many factors that don't directly affect Decision Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Decision Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Decision Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Decision Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.